Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Claire W, Hallahan"'
Autor:
Stephen A. Migueles, Daniel Mendoza, Matthew G. Zimmerman, Kelly M. Martins, Sushila A. Toulmin, Elizabeth P. Kelly, Bennett A. Peterson, Sarah A. Johnson, Eric Galson, Kate O. Poropatich, Andy Patamawenu, Hiromi Imamichi, Alexander Ober, Catherine A. Rehm, Sara Jones, Claire W. Hallahan, Dean A. Follmann, Mark Connors
Publikováno v:
EBioMedicine, Vol 2, Iss 1, Pp 46-58 (2015)
Understanding natural immunologic control over Human Immunodeficiency Virus (HIV)-1 replication, as occurs in rare long-term nonprogressors/elite controllers (LTNP/EC), should inform the design of efficacious HIV vaccines and immunotherapies. Durable
Externí odkaz:
https://doaj.org/article/60154f40c4b14234b23ce35943e03c38
Autor:
Daniel Mendoza, Stephen A Migueles, Julia E Rood, Bennett Peterson, Sarah Johnson, Nicole Doria-Rose, Douglas Schneider, Eva Rakasz, Matthew T Trivett, Charles M Trubey, Vicky Coalter, Claire W Hallahan, David Watkins, Genoveffa Franchini, Jeffrey D Lifson, Mark Connors
Publikováno v:
PLoS Pathogens, Vol 9, Iss 2, p e1003195 (2013)
Although the study of non-human primates has resulted in important advances for understanding HIV-specific immunity, a clear correlate of immune control over simian immunodeficiency virus (SIV) replication has not been found to date. In this study, C
Externí odkaz:
https://doaj.org/article/e6ac21eaaf154a5ab923f12404de0e7c
Autor:
Stephen A Migueles, Julia E Rood, Amy M Berkley, Tiffany Guo, Daniel Mendoza, Andy Patamawenu, Claire W Hallahan, Nancy A Cogliano, Nicole Frahm, Ann Duerr, M Juliana McElrath, Mark Connors
Publikováno v:
PLoS Pathogens, Vol 7, Iss 2, p e1002002 (2011)
If future HIV vaccine design strategies are to succeed, improved understanding of the mechanisms underlying protection from infection or immune control over HIV replication remains essential. Increased cytotoxic capacity of HIV-specific CD8+ T-cells
Externí odkaz:
https://doaj.org/article/491084109ab54091b90f74f1a7abd2af
Autor:
Steven J Reynolds, Cissy Kityo, Claire W Hallahan, Geoffrey Kabuye, Diana Atwiine, Frank Mbamanya, Francis Ssali, Robin Dewar, Marybeth Daucher, Richard T Davey, Peter Mugyenyi, Anthony S Fauci, Thomas C Quinn, Mark R Dybul
Publikováno v:
PLoS ONE, Vol 5, Iss 4, p e10307 (2010)
Short cycle treatment interruption could reduce toxicity and drug costs and contribute to further expansion of antiretroviral therapy (ART) programs.A 72 week, non-inferiority trial enrolled one hundred forty six HIV positive persons receiving ART (C
Externí odkaz:
https://doaj.org/article/e9266d96ceae4c009bf03922e0c95b03
Autor:
Jennifer Hartt Meyers, J Shawn Justement, Claire W Hallahan, Eric T Blair, Yongming A Sun, M Angeline O'Shea, Gregg Roby, Shyam Kottilil, Susan Moir, Colin M Kovacs, Tae-Wook Chun, Anthony S Fauci
Publikováno v:
PLoS ONE, Vol 2, Iss 5, p e458 (2007)
Plasmacytoid dendritic cells (pDCs) are important mediators of innate immunity that act mainly through secretion of interferon (IFN)-alpha. Previous studies have found that these cells can suppress HIV in vitro; additionally, pDCs have been shown to
Externí odkaz:
https://doaj.org/article/d44c8696110246179f9b5da77b358390
Autor:
Bennett A. Peterson, Matthew G. Zimmerman, Andy Patamawenu, Stephen A. Migueles, Daniel Mendoza, Claire W. Hallahan, Sushila A. Toulmin, Eric Galson, Kelly M. Martins, Dean Follmann, Elizabeth P. Kelly, Mark Connors, Catherine Rehm, Alexander Ober, Sarah A. Johnson, Kate O. Poropatich, Hiromi Imamichi, Sara Jones
Publikováno v:
EBioMedicine, Vol 2, Iss 1, Pp 46-58 (2015)
EBioMedicine
EBioMedicine
Understanding natural immunologic control over Human Immunodeficiency Virus (HIV)-1 replication, as occurs in rare long-term nonprogressors/elite controllers (LTNP/EC), should inform the design of efficacious HIV vaccines and immunotherapies. Durable
Autor:
Olivia R. Fankuchen, Claire W. Hallahan, Anthony S. Fauci, Jana Blazkova, Kathleen R. Gittens, Jesse S. Justement, Danielle Murray, Erika Benko, Colin Kovacs, Susan Moir, Tae-Wook Chun
Publikováno v:
Proceedings of the National Academy of Sciences. 111:13151-13156
Several highly potent and broadly neutralizing monoclonal antibodies against HIV have recently been isolated from B cells of infected individuals. However, the effects of these antibodies on the persistent viral reservoirs in HIV-infected individuals
Autor:
Rupert Kaul, Connie J. Kim, Susan Moir, Cecilia T. Costiniuk, Gabor Kandel, Joseph P. Casazza, Erika Benko, Tae-Wook Chun, Colin Kovacs, Mario A. Ostrowski, Richard A. Koup, Jana Blazkova, J. Shawn Justement, Claire W. Hallahan, Anthony S. Fauci, Danielle Murray
Publikováno v:
The Journal of Infectious Diseases. 208:1443-1447
Elite controllers suppress human immunodeficiency virus (HIV) viremia to below the limit of detection in the absence of antiretroviral therapy (ART). However, precise frequencies of CD4(+) T cells carrying replication-competent HIV and/or the dynamic
Autor:
Timothy Jancel, Tiffany Kim, Scott R. Penzak, Steven M. Holland, Claire W. Hallahan, Pamela A. Shaw, Alexandra F. Freeman
WHAT IS KNOWN AND OBJECTIVE Posaconazole is an extended-spectrum triazole antifungal with activity against a variety of clinically significant yeasts and moulds. Posaconazole is not currently approved by the U.S. Food and Drug Administration for use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff278215464ecfb8c23571c94c99f47b
https://europepmc.org/articles/PMC5209268/
https://europepmc.org/articles/PMC5209268/
Autor:
Claire W. Hallahan, Anthony S. Fauci, Colin Kovacs, J. Shawn Justement, Tae-Wook Chun, Susan Moir, Danielle Murray
Publikováno v:
The Journal of Infectious Diseases. 204:135-138
Residual plasma viremia (50 copies/mL) persists in certain human immunodeficiency virus (HIV)-infected individuals receiving antiretroviral therapy (ART); however, the relationship between the degree of residual plasma viremia, the size of HIV reserv